Xiaohui Wang, Zheng Song, Xianhuo Wang, Huilai Zhang. "Novel triplet combination of orelabrutinib, lenalidomide, and rituximab as frontlinetherapy for mantle cell lymphoma: Final results of polaris multicenter phase II study." Blood, 2025. doi:10.1182/blood-2025-1803